ACTU: Actuate Therapeutics, Inc. Stock

SIC 7372 – Prepackaged Software

Valuation
Market Cap ($M) 160.75
Enterprise Value ($M) 152.10
Book Value ($M) 0.10
Book Value / Share 0.01
Price / Book 1,542.87
NCAV ($M) -0.01
NCAV / Share -0.00
Price / NCAV -25,266.48

Profitability (mra)
Return on Invested Capital (ROIC) -261.89
Return on Assets (ROA) -10.11
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.05
Current Ratio 1.05

Balance Sheet (mrq) ($M)
Current Assets 9.21
Assets 9.32
Liabilities 9.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.16
Net Income -27.29
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.84
Cash from Investing 0.00
Cash from Financing 27.53

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
08-19 13D BIOS Fund I, LP 52.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,016 45,316 6.66
2025-04-16 4,785 68,154 7.02
2025-04-15 14,581 50,663 28.78
2025-04-14 4,842 30,345 15.96

(click for more detail)

Similar Companies
AISP – Airship AI Holdings, Inc. APPF – AppFolio, Inc.


Financial data and stock pages provided by
Fintel.io